ACUTE LYMPHOBLASTIC LEUKEMIA - acute myeloblastic leukemia.
Conditions
Interventions
Intervention 1: Intervention group: Intervention Group: The intervention group will be divided into two subgroups: the first subgroup will receive ciprofloxacin at a dose of 20 mg/kg/day (maximum 750
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Months to 18 Years
Inclusion criteria
Inclusion criteria: children with hematologic malignancies
Exclusion criteria
Exclusion criteria: allergy to cyprofloxacin or co amoxiclav malignancies other than hematologic like wilms tumor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutropenic fever. Timepoint: every 2 hours. Method of measurement: Using a digital forehead thermometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bacterial or viral infection. Timepoint: daily. Method of measurement: blood culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDaryoush Ghanbari
Oroumia University of Medical Sciences
Outcome results
None listed